Explore PMI Science, where innovation meets harm reduction. Learn about our scientists, smoke-free research, and commitment to transparency in research.
PMI offers smoke-free alternatives with the potential to reduce the risk of harm for adult smokers who do not quit. Learn about harm reduction, the role of nicotine, and the regulation of smoke-free products.
Discover PMI's rigorous scientific approach to smoke-free products and product assessment. Dive into our research results, peer-reviewed publications, independent research, and expert reports.
PMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.
Explore the latest insights and stay informed about upcoming events and conference presentations from PMI scientists.
Ask a question or send us feedback. We're happy to answer.
Explore PMI Science, where innovation meets harm reduction. Learn about our scientists, smoke-free research, and commitment to transparency in research.
PMI offers smoke-free alternatives with the potential to reduce the risk of harm for adult smokers who do not quit. Learn about harm reduction, the role of nicotine, and the regulation of smoke-free products.
Discover PMI's rigorous scientific approach to smoke-free products and product assessment. Dive into our research results, peer-reviewed publications, independent research, and expert reports.
PMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.
Explore the latest insights and stay informed about upcoming events and conference presentations from PMI scientists.
Ask a question or send us feedback. We're happy to answer.
Different approaches have been reported in the literature to reduce the tobacco-specific nitrosamine (TSNA) levels in mainstream smoke (MSS). The reduction of TSNA in the raw tobacco is an approach that has received much attention in recent years. Different elements determine the level of TSNA in MSS: During combustion, part of the TSNA in the cigarette filler can transfer into smoke while another portion can undergo thermal degradation. Moreover, it is possible that TSNA can be pyrosynthesized and that concomitant synergetic effects between the blend components can also occur. Depending on their extent, the formation and degradation of nitrosamines during the combustion process might have an important impact on TSNA level in the smoke of blended cigarettes and might lead to MSS TSNA deliveries which would not parallel that of the blend components. A study was therefore undertaken to assess the feasibility of predicting the TSNA deliveries of blended products on the basis of the TSNA deliveries of the individual blend components. A highly simplified blend-model was chosen, including laminar Virginia, burley and Oriental tobaccos in fixed proportions. A set of one-, two- and three-component prototypes was prepared with various combinations of highand low-TSNA Virginia and burley tobacco. The pre-formed TSNA levels of the different blend components and the MSS delivery of the prototypes were determined. The TSNA deliveries of the blended prototypes were found to be in good agreement with the predictions based on both the MSS TSNA delivery and the pre-formed TSNA content of the individual blend components. This study showed that predicting MSS TSNA levels in the smoke of blended cigarettes could probably be achieved with adequate accuracy from the levels measured in the smoke of the laminar blend components. Strong indications were obtained that such predictions could be made from the preformed TSNA content of the raw tobacco. With respect to the reduction of TSNA in MSS, the reported results provided evidence that procuring tobaccos with very low levels of pre-formed TSNA would be an effective strategy to reduce the content of TSNA in MSS.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.